One Nucleus announces new director

Industry expert to support life sciences membership group

One Nucleus, a membership company for international life science and healthcare companies based in Cambridge and London in the UK, has appointed Dr Alan Palmer as a director. Palmer is co-founder and currently chief scientific officer at MS Therapeutics and has 30 years’ experience in the biotechnology sector in roles spanning academia, research and industry.

Palmer has close ties with the London life science and healthcare community and was a strong supporter of the London Biotechnology Network (LBN), which is now part of One Nucleus.

Commenting on his appointment, Palmer said: “I have worked with Harriet Fear and Tony Jones for many years and am very excited about the merger of ERBI and LBN to form One Nucleus. These are challenging times and One Nucleus is extremely well placed to support the biotechnology sector.’

Harriet Fear, ceo of One Nucleus, added: ‘Alan is a great addition to the team. He has a deep understanding of the needs of One Nucleus members, and this coupled with his academic and pharma background makes him an ideal director for One Nucleus.’

You may also like

Media

BioPharma Dynamics proudly sponsor GMCC Excellence Awards

BioPharma Dynamics is proud to continue their headline sponsorship of Greater Manchester Chamber of Commerce Excellence Awards, championing success and achievements of businesses within the Greater Manchester region
Media

Chemspec Europe 2024 conference programme unveiled

A detailed look at key speakers, sessions, and networking opportunities at the international exhibition
Media

Curia receives 2024 CDMO leadership award

Curia recognised for its service in the CDMO industry
Media

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN

Biovian and 3P Biopharmaceuticals, two leading biologics CDMOs, announce their combination to establish a new pan-European leader in their field
Media

Royal Society of Chemistry and TIB co-create next generation Open Access consortium model

The agreement delivers shared goals of equity for institutions, a community approach and universal open access for authors
Media

Thermo Fisher launches industry’s first off-the-shelf solution to streamline and automate cell therapy manufacturing

Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing
Media

Two new appointed members have joined the RSC’s Board of Trustees

The dual appointment will add invaluable commercial acumen and project leadership experience
Subscribe now